Daily Archives: July 17, 2017

FDA OKs First ‘Extended’ Adjuvant Treatment for HER2 Breast Cancer

The FDA has approved a new drug for patients with early-stage HER2-positive breast cancer who have completed trastuzumab and want “extended” adjuvant therapy. FDA Approvals …read more

What to Know About the NAMS Updated Position on Hormone Therapy

Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. Medscape Ob/Gyn …read more